| 
		
		 UNICEF 
		sends syringes to Maldives, Ivory Coast, for COVAX vaccine rollout
   Send a link to a friend 
		[February 23, 2021]  
		LONDON (Reuters) - The U.N. children's fund 
		UNICEF said on Tuesday it had sent an initial 100,000 syringes for 
		COVID-19 vaccines to the Maldives in preparation for first deliveries of 
		Pfizer and AstraZeneca shots under the COVAX vaccine-sharing plan. | 
        
            | 
			
			 The syringes, as well as 1,000 safety boxes for vaccine storage, are 
			expected to arrive in the Maldives on Tuesday, UNICEF said. Other 
			recipient countries in the first wave of shipments include Ivory 
			Coast and Sao Tome and Principe. 
 Tuesday's shipment will be followed in the next few weeks by 
			deliveries of some 14.5 million 0.5 millilitre (ml) and 0.3 ml 
			syringes to more than 30 countries, UNICEF said in a statement.
 
			
			 
			The COVAX facility - co-led by the World Health Organization, the 
			GAVI vaccine alliance and others - earlier this month allocated 
			around 330 million doses of COVID-19 vaccines for poorer countries. 
			It aims to deliver these and millions more in the first half of 
			2021. 
			
            [to top of second column] | 
			
			 "It is critical to have 
								adequate supplies of syringes already in place 
								in every country before the vaccine arrives so 
								that the vaccine can be administered safely," 
								said UNICEF's executive director Henrietta Fore.
 This would allow immunisation to start 
								immediately, she said, and "help turn the tide 
								on this terrible virus".
 
 UNICEF said the 0.5 ml syringes would be for use 
								with the AstraZeneca COVID-19 vaccine made by 
								Serum Institute of India, and the 0.3 ml ones 
								would be for the Pfizer-BioNTech shot.
 
 (Reporting by Kate Kelland; Editing by Andrew 
								Cawthorne)
 
			[© 2021 Thomson Reuters. All rights 
				reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content |